Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Inovio Pharma (INO)

Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 251,596
  • Shares Outstanding, K 25,911
  • Annual Sales, $ 830 K
  • Annual Income, $ -135,120 K
  • 60-Month Beta 0.99
  • Price/Sales 302.71
  • Price/Cash Flow N/A
  • Price/Book 2.37
Trade INO with:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 65.42%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,391.46% on 08/14/23
  • IV Low 0.00% on 06/12/24
  • Put/Call Vol Ratio 0.13
  • Today's Volume 81
  • Volume Avg (30-Day) 452
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 15,511
  • Open Int (30-Day) 16,219

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -1.15
  • Number of Estimates 3
  • High Estimate -0.94
  • Low Estimate -1.28
  • Prior Year -1.56
  • Growth Rate Est. (year over year) +26.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.22 +2.82%
on 06/10/24
13.44 -29.46%
on 05/16/24
-1.17 (-10.99%)
since 05/10/24
3-Month
8.35 +13.53%
on 04/16/24
14.75 -35.72%
on 04/01/24
-2.03 (-17.64%)
since 03/12/24
52-Week
3.89 +143.83%
on 11/10/23
14.75 -35.72%
on 04/01/24
+3.53 (+59.43%)
since 06/12/23

Most Recent Stories

More News
5 Analyst-Approved Stocks Set to Join the Russell Microcap Index

As a part of the annual Russell index rebalancing, here are five stocks set to join the Russell Microcap Index this year, which analysts have tagged with consensus ‘buy’ ratings.

HUT : 10.93 (+10.07%)
^BTCUSD : 68,182.21 (+0.14%)
URG : 1.4900 (+2.05%)
LUNR : 4.16 (+0.24%)
INO : 9.48 (-2.37%)
AISP : 4.38 (-5.19%)
Better Buy: Inovio Pharmaceuticals vs. Novavax

Both biotechs have been struggling for a while, but there might be some hope for them.

PFE : 27.66 (-1.32%)
NVAX : 15.86 (-5.17%)
INO : 9.48 (-2.37%)
Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript

INO earnings call for the period ending March 31, 2024.

INO : 9.48 (-2.37%)
Inovio: Q1 Earnings Snapshot

Inovio: Q1 Earnings Snapshot

INO : 9.48 (-2.37%)
This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?

Can the biotech succeed after a string of failures?

INO : 9.48 (-2.37%)
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript

INO earnings call for the period ending December 31, 2023.

INO : 9.48 (-2.37%)
Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript

INO earnings call for the period ending September 30, 2023.

INO : 9.48 (-2.37%)
Inovio: Q3 Earnings Snapshot

Inovio: Q3 Earnings Snapshot

INO : 9.48 (-2.37%)
INOVIO Announces U.S. FDA Breakthrough Therapy Designation Granted for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

INO : 9.48 (-2.37%)
Inovio Pharmaceuticals (INO) Q2 2023 Earnings Call Transcript

INO earnings call for the period ending June 30, 2023.

INO : 9.48 (-2.37%)

Business Summary

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled...

See More

Key Turning Points

3rd Resistance Point 10.74
2nd Resistance Point 10.46
1st Resistance Point 9.97
Last Price 9.48
1st Support Level 9.21
2nd Support Level 8.93
3rd Support Level 8.44

See More

52-Week High 14.75
Fibonacci 61.8% 10.60
Last Price 9.48
Fibonacci 50% 9.32
Fibonacci 38.2% 8.04
52-Week Low 3.89

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar